U.S. markets closed

Allmed Medical Products Co., Ltd (002950.SZ)

Shenzhen - Shenzhen Delayed Price. Currency in CNY
Add to watchlist
24.49+0.15 (+0.62%)
At close: 4:29PM CST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in CNY

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 9/30/2020
Current
6/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
15.48B17.97B15.04B8.80B8.78B
Enterprise Value 3
16.19B17.93B15.41B9.17B9.17B
Trailing P/E
17.8149.0346.6727.3131.58
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
5.267.316.243.653.62
Price/Book (mrq)
6.348.357.704.514.76
Enterprise Value/Revenue 3
4.6110.8225.7914.3114.86
Enterprise Value/EBITDA 6
13.0324.53141.1264.0372.55

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 317.55%
S&P500 52-Week Change 315.54%
52 Week High 360.81
52 Week Low 319.06
50-Day Moving Average 326.49
200-Day Moving Average 329.82

Share Statistics

Avg Vol (3 month) 312.88M
Avg Vol (10 day) 36.12M
Shares Outstanding 5633.27M
Float 166.75M
% Held by Insiders 178.41%
% Held by Institutions 13.18%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.4
Forward Annual Dividend Yield 41.64%
Trailing Annual Dividend Rate 30.40
Trailing Annual Dividend Yield 31.64%
5 Year Average Dividend Yield 4N/A
Payout Ratio 429.14%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 05, 2020
Last Split Factor 21:1
Last Split Date 3Jun 05, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2019
Most Recent Quarter (mrq)Jun 30, 2020

Profitability

Profit Margin 26.35%
Operating Margin (ttm)26.52%

Management Effectiveness

Return on Assets (ttm)15.59%
Return on Equity (ttm)42.26%

Income Statement

Revenue (ttm)3.51B
Revenue Per Share (ttm)5.55
Quarterly Revenue Growth (yoy)185.60%
Gross Profit (ttm)777.3M
EBITDA 1.06B
Net Income Avi to Common (ttm)925.64M
Diluted EPS (ttm)1.46
Quarterly Earnings Growth (yoy)999.80%

Balance Sheet

Total Cash (mrq)1.18B
Total Cash Per Share (mrq)1.87
Total Debt (mrq)893.99M
Total Debt/Equity (mrq)35.39
Current Ratio (mrq)1.95
Book Value Per Share (mrq)3.98

Cash Flow Statement

Operating Cash Flow (ttm)1.06B
Levered Free Cash Flow (ttm)442.16M